Friday, March 02, 2018 11:40:22 AM
I have kept a certain number of shares of Nanologix and traded others, having averaged down I've achieved some very respectable gains in trading. I view the technology just for the packaging as a great potential income source for them and with the N-Assay I believe that will end up as over the top. After trading in and out and taking profit on swings numerous times, such as late 2016 when I sold 85% of my shares at $0.16 per share after having bought them at a fraction of that, I ended up in the situation where all my initial costs were recouped plus making a healthy after tax profit, I've been able to set aside a substantial trading amount, and believe it will serve me well as a long term investment with reinvestment in Nanologix and investments in other companies in medical and other sectors. I've bought other stocks for dividend earnings and Nanologix is one of the few small companies in which I have shares.
I differ with the doomsayers here, believing Nanologix will grow, whether rapidly or slowly, I expect it is one of the few gems in penny stocks.
EI
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM